» Articles » PMID: 8621793

Inferior Petrosal Sinus Sampling in Healthy Subjects Reveals a Unilateral Corticotropin-releasing Hormone-induced Arginine Vasopressin Release Associated with Ipsilateral Adrenocorticotropin Secretion

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1996 May 1
PMID 8621793
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Arginine vasopressin (AVP) acts synergistically with corticotropin-releasing hormone (CRH) to stimulate ACTH release from the anterior pituitary. In a previous study of bilateral simultaneous inferior petrosal sinus (IPS) sampling in healthy human subjects, we observed lateralized ACTH secretion, suggesting lateralized secretion of an ACTH-regulating hypothalamic factor. To investigate this possibility, we measured ACTH, CRH, AVP, and oxytocin (OT) levels in the IPS and the peripheral circulation in nine normal volunteers, before and after 1 microgram/kg i.v. bolus ovine CRH (oCRH). At baseline, ACTH, AVP, and OT exhibited a significant (P < 0.05) two to threefold intersinus gradient (ISG), indicating the existence of a dominant petrosal sinus. Endogenous CRH was undetectable in all samples. Despite similar exogenous oCRH levels in both petrosal sinuses, oCRH caused a significant increase (P < 0.001) in the ACTH ISG (15.8 +/- 5.6, mean +/- SEM), suggesting increased responsiveness of one dominant side of the anterior pituitary. This was associated with an ipsilateral CRH-induced AVP release and a significant increase (P < 0.01) in the AVP ISG (8.6 +/- 2.3), suggesting lateralized AVP secretion by the hypothalamus. Furthermore, the increased AVP ISG after oCRH correlated strongly with the ACTH ISG (r = 0.92, P < 0.01). oCRH administration did not affect OT. These findings suggest that there is a dominant petrosal sinus in healthy volunteers that appears to reflect a dominant side of the adenohypophysis, characterized by increased functional activity and/or responsiveness of the pituitary corticotrophs. This may reflect lateralized hypothalamic and/or suprahypothalamic function resulting in CRH-responsive lateralized secretion of AVP from parvocellular and/or magnocellular axons in the median eminence and the posterior pituitary. Although the functional and teleologic significance of these findings remains to be investigated, our data suggest a novel mechanism for CRH-mediated ACTH release, namely CRH-induced release of AVP which then enhances CRH action on the corticotrophs. Furthermore, our data represent the first direct evidence for the concept of brain lateralization with respect to neuroendocrine secretion.

Citing Articles

Oxytocin levels in response to CRH administration in hypopituitarism and hypothalamic damage: a randomized, crossover, placebo-controlled trial.

Asla Q, Garrido M, Urgell E, Terzan S, Santos A, Fernandez M Sci Rep. 2025; 15(1):2360.

PMID: 39824923 PMC: 11742408. DOI: 10.1038/s41598-025-86566-y.


Glucocorticoids and Water Balance: Implications for Hyponatremia Management and Pituitary Surgery.

Castle-Kirszbaum M, Goldschlager T, Shi M, Fuller P Neuroendocrinology. 2023; 113(8):785-794.

PMID: 37062279 PMC: 10389798. DOI: 10.1159/000530701.


Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management.

Warren A, Grossmann M, Christ-Crain M, Russell N Endocr Rev. 2023; 44(5):819-861.

PMID: 36974717 PMC: 10502587. DOI: 10.1210/endrev/bnad010.


Extreme Hyponatremia Complicated by Osmotic Demyelination in a Previously Healthy Young Individual.

Quigley N, Garneau A, Haydock L, Isenring P Can J Kidney Health Dis. 2022; 9:20543581221130686.

PMID: 36406868 PMC: 9669670. DOI: 10.1177/20543581221130686.


The left-right side-specific endocrine signaling in the effects of brain lesions: questioning of the neurological dogma.

Bakalkin G Cell Mol Life Sci. 2022; 79(11):545.

PMID: 36219330 PMC: 9553812. DOI: 10.1007/s00018-022-04576-9.


References
1.
Rittmaster R, Cutler Jr G, Sobel D, Goldstein D, Koppelman M, Loriaux D . Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J Clin Endocrinol Metab. 1985; 60(5):891-5. DOI: 10.1210/jcem-60-5-891. View

2.
Manni A, Latshaw R, Page R, Santen R . Simultaneous bilateral venous sampling for adrenocorticotropin in pituitary-dependent cushing's disease: evidence for lateralization of pituitary venous drainage. J Clin Endocrinol Metab. 1983; 57(5):1070-3. DOI: 10.1210/jcem-57-5-1070. View

3.
Wittling W, Schweiger E . Neuroendocrine brain asymmetry and physical complaints. Neuropsychologia. 1993; 31(6):591-608. DOI: 10.1016/0028-3932(93)90054-4. View

4.
Yanovski J, Cutler Jr G, Doppman J, Miller D, Chrousos G, Oldfield E . The limited ability of inferior petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing's disease from pseudo-Cushing states or normal physiology. J Clin Endocrinol Metab. 1993; 77(2):503-9. PMC: 5705014. DOI: 10.1210/jcem.77.2.8393887. View

5.
Carlson D, Nabavian A, Brown L, GANN D . Microinjections of corticotropin-releasing hormone into the medial parabrachial nucleus facilitate plasma vasopressin in cats. Ann N Y Acad Sci. 1993; 689:480-3. DOI: 10.1111/j.1749-6632.1993.tb55575.x. View